Is AgeX Therapeutics Inc (AGE) Stock a Good Value?
Wednesday, June 15, 2022 01:34 PM | InvestorsObserver Analysts
Mentioned in this article
AgeX Therapeutics Inc (AGE) stock has fallen -50.00% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives AGE stock a score of 35 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 21. AGE's rank also includes a long-term technical score of 84.
AGE has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on AGE!
AgeX Therapeutics Inc (AGE) stock is higher by 4% while the S&P 500 is higher by 0.88% as of 12:29 PM on Wednesday, Jun 15. AGE is higher by $0.03 from the previous closing price of $0.68 on volume of 26,361 shares. Over the past year the S&P 500 is lower by -11.27% while AGE has fallen -50.00%. AGE lost -$0.24 per share in the over the last 12 months.
Click Here to get the full Stock Report for AgeX Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter